Dexcom Insider Selling Surge: Trust Drops 6,539 Shares in Rapid 10‑b‑5 Plan, Hinting at Steady Exit Strategy.
Dexcom insider sales rise: trust cuts stake while executives sell, yet the company’s growth outlook stays strong.
3 minutes to read
DEXCOM INC
CFO’s Planned Sell‑Off Continues Amid Board Expansion as Dexcom Maintains Solid Growth Outlook
Dexcom CFO’s 3,638‑share sale is a routine, plan‑driven move amid board expansion, showing solid fundamentals and no downside risk for investors.
3 minutes to read
Dexcom Inc. Grants 5,841 RSUs to Trustee Boehnlein Glenn S., Sparking Mild Stock Uptick and Investor Buzz
Dexcom’s 5,841‑share RSU grant signals strong leadership alignment and modest future dilution, giving investors confidence in long‑term value.
3 minutes to read